Clofazimine (CFZ) is a phenazine derivative used for treatment of leprosy, MDR-TB and XDR-TB. There is recent interest in understanding how CFZ works following the demonstration of its unique ability to shorten the treatment of MDR-TB. However, the target of CFZ in mycobacteria has remained elusive. Here, we show that CFZ binds to mycobacterial integration host factor (mIHF), which is an essential nucleoid associated protein in mycobacteria involved in DNA protection, chromosome organization and global gene regulation. We demonstrate that CFZ inhibits mIHF binding to DNA and interferes with mycobacterial gene expression. This mode of action is unique among all antibiotics including antimycibacterial agents and may help to explain its unusual action against Mycobacterium tuberculosis. Our study provides new insight about the mechanism of action of this intriguing drug and has implications for developing more effective treatment of TB.
. Various studies suggest that CFZ seems to have multiple effects such as binding to DNA 7 , interfering with redox cycling 8 , causing membrane destabilization and dysfunction 9 , and production of reactive oxygen species 10 . To identify potential targets of CFZ, we used a proteomic approach to find proteins that could bind to CFZ by affinity chromatography ( fig. s1 and fig. s2 ), a strategy which we previously used to successfully identify a target of pyrazinamide 11 .
Lysates of M. tuberculosis were allowed to interact with the CFZ-coupled agarose beads and the control agarose beads in columns by affinity chromatography, followed by analysis of the eluted fractions on SDS-PAGE. Several protein bands eluted from the CFZ-agarose column were seen but no visible band was found from the control column (Fig. 1) . Mass sepctrometry analysis of the candidate proteins that were bound to CFZ identified four ribosomal proteins (RplD, RpsP, RpsQ and RplD) and the mycobacterial integration host factor (mIHF, Rv1388). Based on Coomassie Blue staining, mIHF was the most abundant protein with an apparent molecular weight of about 12 kDa (Fig. 1) .
The annotated mIHF from the M. tuberculosis H37Rv genome database indicates that its full length is 190 amino acid residues 12 ( fig. s3 ). On the other hand, mIHF from M. tuberculosis when overexpressed as either a C-terminal 111 aa or 190 aa full length protein was shown to be able to bind DNA and compact DNA in vitro 13, 14 . To determine which is the correct size of the mature protein, we cut out the 12 kDa band from the gel (Fig. 1 ) and subjected it to N-terminal amino acid sequencing by Edman degradation and identified the first 5 amino acid residues to be -ALPQL. This finding indicates that the mIHF from M. tuberculosis is in fact 105 aa, rather than the 190 aa as annotated in the database, and is in keeping with the size of the M. smegmatis mIHF 15 .
The mIHF is rich in strongly basic residues (22/105 residues in lysine and arginine) with a calculated isolectric point 9.91 and its secondary structure was rich in helical content. These features are consistent with the finding that mIHF is a DNA binding protein 13 . To investigate if 105 aa mIHF of M. tuberculosis binds to DNA, the recombinant M. tuberculosis mIHF was overexpressed in E. coli strain BL21 (DE3) and purified ( fig. s4 ). The purified mIHF interacted with both circular and linear plasmid DNA in a concentration dependent manner as shown by To assess whether mIHF interacts with CFZ directly, a gel shift assay was used to analyze the complex formation between the recombinant M. tuberculosis mIHF and CFZ. The acidic native gel was used to separate native basic proteins 16 , and the complex formation of native mIHF and CFZ was visualized on acidic native gels. The results showed that the mIHF and CFZ formed a complex (Fig. 2a) . However, no complex formation was observed with the control TB drug rifampin (RIF) which has similar color as CFZ (Fig. 2b) or with another control, oil red O, which is a fat-soluble dye with similar characteristics as CFZ (Fig. 2c ), even at a high concentration up to 500 μg/ml. Therefore, CFZ interacted with M. tuberculosis mIHF s p e c i f i c a l l y .
To further examine the effect of CFZ on mIHF binding to DNA, mIHF was incubated with different concentrations of CFZ (Fig. 3a) , with RIF ( Fig. 3b ) or oil red O (Fig. 3c) as controls, respectively. As shown in Fig. 3a , CFZ inhibited mIHF and DNA complex formation in a concentration dependent manner (Fig. 3a , Lane 2-13). In contrast, the control drug RIF (Fig. 3b , Lane 2-13) and oil red O (Fig. 3c , Lane 2-13) had no effect on mIHF-DNA interaction. In addition, CFZ alone did not cause altered DNA migration on agarose gel ( fig. s6 ), indicating CFZ does not bind to DNA directly, but instead binds to DNA indirectly via mIHF. This is in contrast to previous studies that claimed CFZ directly binds to DNA 7, 17, 18 .
To investigate whether CFZ affects mIHF behavior in vivo in mycobacterial cell, a fusion protein of mIHF with red fluorescent protein (RFP) was constructed under the control by a tetracycline inducible promoter. The mIHF-RFP fusion protein was found to localize at nucleoid zone in M. tuberculosis H37Ra/pUV15tet-mIHF-RFP strain at log phase when inducer, anhydrotetracycline (ATc), was added (Fig. 4 a and c) . The mIHF-RFP protein was localized at nucleoid zone as a tight spot. However, clusters of red fluorescence were diffused to the whole cell when the mIHF-RFP induced culture was exposed to CFZ (Fig. 4 b) , indicating that CFZ changed mIHF location in the M. tuberculosis cell. To evaluate whether mIHF location is altered by CFZ, M. tuberculosis H37Ra/pUV15tet-mIHF-RFP strain was exposed to different concentrations of CFZ first and then the expression of mIHF-RFP was observed by microscopy upon tetracycline induction. Interestingly, the red fluorescence was diminished depending on the CFZ concentration. There were fewer fluorescent cells and lower fluorescent density in the 1 μg/ml (Fig. 4 d) and 5 μg/ml (Fig. 4 e) CFZ treated groups than the untreated control group (Fig.   4c ). Furthermore, no visible red spot at nucleoid zone was seen with the 25 μg/ml CFZ treated group (Fig. 4 f) While overexpression of drug targets often causes drug resistance, we found that overexpression of mIHF did not cause significant CFZ resistance in M. tuberculosis compared with the parental strain and empty vector control strain. The same phenomenon was observed with the target of linezolid, RplC whose overexpression did not cause resistance to linezolid 21 . In fact, overexpression of the drug target could have a wide range of effects in terms of resistance to that drug, ranging from increase, unchanged, to even decrease 22 . Since mIHF is an abundant protein that is present at the same high levels in all growth phases in M. tuberculosis 20 , any exogenous overexpression on a very high background levels of mIHF would be expected to produce hardly any additional resistance. Further studies are needed to address whether mIHF expression levels contribute to or correlate with CFZ resistance. Although mutations in three genes, Rv0678, Rv2535c and Rv1979c, are typically associated with CFZ resistance 23 , 24 , 25 , no mIHF mutation was found in those CFZ resistant mutants. Future studies are necessary to systematically characterize CFZ-resistant clinical strains to determine the role of mIHF gene in mechanism of CFZ resistance in M. tuberculosis. mIHF is a small, heat-stable protein that promotes the integrative recombination of phage DNA into the chromosome through formation of specific integrase-mIHF-attP complexes in mycobacteria There is only one copy of mIHF in mycobacteria which is quite distinct from host integration factor in E. coli 15 . mIHF is essential for M. smegmatis viability and M. tuberculosis growth 26, 27 . That mIHF binding to DNA and bending DNA 13 suggests that it is a global gene expression regulator in M. tuberculosis with more functions than that of E. coli. Many studies indicated that the interaction between IHF and DNA is complex, with IHF binding to DNA by different modes that induce different DNA bending patterns, and these DNA binding modes are sensitive to different conditions 28, 29 . Our findings that mIHF binds to DNA and that CFZ affected mIHF binding to DNA and altered mIHF location in vivo suggest that CFZ could inhibit gene expression by affecting mIHF and DNA interaction in M. tuberculosis causing the cell to be more susceptible to secondary attacks by other drugs or reactive oxygen species (ROS) or nucleases that damage DNA. Such a mechanism of action is consistent with recent observation that CFZ activity is enhanced mainly by drugs such as fluoroquinolone, aminoglycoside, and acid pH and PZA that could produce ROS or damage DNA 30 . Further studies are required to test this possibility in the future. Our study provides novel insights about the unique mechanism of action of CFZ and implicates mIHF as a novel target for developing new drugs for overcoming drug resistance and more effective treatment of persistent mycobacterial infections.
Methods
Preparation of CFZ affinity chromatography column CFZ was coupled to the immobilized diaminodipropylamine (DADPA) resin (G-Biosciences, St. Louis, MO, USA) to generate an affinity chromatographic matrix according to the manufacturer's instructions. Briefly, 10 ml of immobilized DADPA resin was centrifuged at 700 g for 2 minutes to remove the storage buffer. The resin was washed with coupling buffer (0.1M MES, 0.15M NaCl, pH4.7) twice. After washing, the resin was mixed thoroughly in the coupling buffer containing 0.2 μ g/ml CFZ and 1 ml 37% formaldehyde. The column was incubated with gentle agitation at 37 °C overnight. Then the column was washed to remove excess unbound ligand using coupling buffer. The control column was coupled with 37% formaldehyde without CFZ. The columns were washed with three cycles of alternating pH with 0.1 M acetate buffer (pH 4.0) containing 0.5 M NaCl followed by a wash with 0.1 M Tris-HCl buffer pH 8 containing 0.5 M NaCl.
Protein lysate preparation M. tuberculosis H37Ra was cultured in Sauton's medium at 37°C with gentle shaking for three weeks. Sauton's medium consisted of the following composition (per liter): 4 g of L-asparagine, 0.5 g of monopotassium phosphate, 0.5 g of magnesium sulfate, 50 mg of ferric ammonium citrate, 2 g of citric acid, 1 mg of zinc sulfate, and 60 ml of glycerol (with 0.05% Tween 80 added after sterilization). Mycobacterial cells were collected and washed with PBS buffer (pH 7.0) twice. Mycobacterial protein lysates were prepared by sonication followed by collecting the supernatants after centrifugation as described previously 11 . The protein concentration of the lysates was determined by the Bradford method using Pierce™ BCA Protein Assay Kit (Thermo Scientific, USA).
Isolation of CFZ-binding proteins
The columns were equilibrated with PBS buffer pH 7.0. The CFZ-linked column and control column were loaded with the M. tuberculosis lysates (~ 600 mg protein for each column) and incubated at room temperature for 2 hours. Then the columns were washed with PBS buffer to reduce nonspecific binding of proteins until the baseline was stable. The columns were eluted with PBS buffer containing 2 M NaCl. The eluted fractions were run on 4 -20% SDS-PAGE gradient gels, followed by staining with Coomassie Blue.
Identification of CFZ binding proteins from M. tuberculosis
The proteins eluted from the CFZ-agrose column and separated on the SDS-PAGE gel were excised and subjected to in-gel digestion with trypsin followed by analysis by MALDI-TOF, and in parallel, another gel containing the protein bands was transferred to PVDF membrane for Nterminal sequence to identify N-terminal sequencing was performed by Edman degradation method.
Cloning, sequencing, expression and purification of M. tuberculosis integration host factor (mIHF, Rv1388)
The mIHF, encoding the M. tuberculosis integration host factor, was amplified by PCR from M. tuberculosis H37Rv genomic DNA using forward primer 5'-GCGCCCATGGCCCTTCCCCAGTTGACCG -3' containing a NcoI restriction site (underlined) and reverse primer 5'-GCATCTCGAGGGCGGAGCCGAACTTTTCCAGC -3' a XhoI restriction site (underlined). The PCR fragments were digested with NcoI and XhoI (New England BioLabs, Inc., Ipswich, MA, USA), and ligated to plasmid pET28a digested with the same enzymes to construct recombinant plasmid which was confirmed by DNA sequencing. The mycobacterial mIHF protein was overexpressed in log phase E. coli strain BL21 (DE3) after induction with IPTG (1 mM) at 37 °C for 3.5 hours. The supernatant containing the recombinant mIHF was purified on Ni-NTA agarose column. Immobilized recombinant mIHF protein was washed by a 20 -50 mM imidazole gradient and eluted with buffer (20 mM Tris-HCl, 300 mM NaCl, pH 8.0 and 250 mM imidazole). The purified protein was dialyzed against 10 mM TrisHCl buffer (pH 7.5) to remove imidazole and stored at -70 °C for further experiments.
CFZ and mIHF interaction by gel shift assay
Binding reactions (10 μ l) contained recombinant M. tuberculosis H37Rv mIHF 0.18 μ g and different concentration of CFZ or control drug were incubated at 10 mM Tris-HCl, 10 mM MgCl 2 , 1 mM DTT, pH 7.9 at room temperature for 30 min. 2 µl of 5 × loading dye (50% glycerol, 0.25 M acetate-KOH pH 6.8 and trace amount methyl green) were added, tubes were centrifuged for 5 min at 5000 rpm and mIHF-CFZ complexes were separated in acidic native gels, which contained 0.375 M acetate-KOH, pH 4.3, 15% polyacrylamide and 10% glycerol for separating gel and 0.0625 M acetate-KOH pH 6.8, 3% polyacrylamide and 10% glycerol for stacking gel, in running buffer with 0.35 M β -alanine, 0.14 M acetic acid (pH 4.3). Samples were electrophoresed in the stacking gel at 5 mA and then run overnight at 3 mA per gel at room temperature, followed by silver staining. The gel shift results were repeated 3 times. mIHF and DNA interaction mIHF and DNA interaction was analyzed with supercoiled or linearized form of pUC19 plasmid DNA (linearized with HindIII) and mIHF concentrations ranging from 3.125 ng to 200 ng incubated in a buffer containing 10 mM Tris-HCl, pH 7.9; 50 mM NaCl; 10 mM MgCl 2 ; 1 mM DDT on ice for 15 min. The mIHF-DNA complex was analyzed on 0.5% agarose gel following by Ethidium Bromide (EtBr) staining.
Inhibition of mIHf and DNA interaction by CFZ
The CFZ inhibition assay was investigated with different concentrations of CFZ (0.05, 25, 50, 100, and 800 μ g/ml) in the above mIHF (50 ng/reaction) and DNA (50 ng/reaction) binding reaction. CFZ and recombinant H37Rv mIHF were incubated on ice for 30 min. Then mIHF alone or mIHF-CFZ complex was incubated with DNA on ice for 15 min. The mIHF-(CFZ)-DNA complex was analyzed on 0.5% agarose gel, running in 1× TBE buffer and followed by Ethidium Bromide staining.
Localization of mIHF and gene expression interference by CFZ
To fuse red fluorescent protein (RFP) to the C terminal of mIHF, mIHF was PCR-amplified using M. tuberculosis H37Rv genomic DNA as the template and primer pairs as Rv1388F: 5'-GCGCTTAATTAAGAAGGAGATATACATATGGCCCTTCCCCAGTTGACCG-3' and Rv1388R: 5'-GATCAAGCTTGGCGGAGCCGAACTTTTCCAGCAGGG-3'. Red fluorescent protein (RFP) was amplified by PCR and primer pairs as RedF: 5'-CGGAAGCTTGCCTCCTCCGAGGACGTCATC-3' and RedR: 5'-TTCGATATCTTATGCTGCTGCTGCTGCTGCCAGG-3'. Rv1388 and RFP fragments were digested with PacI/HindIII and HindIII/EcoRv, respectively, then cloned into the tetracyclineinducible plasmid pUV15tetORM 31 digested with PacI and EcoRV, resulting in the plasmid pUV15-mIHF-RFP. Then, recombinant constructs were verified by DNA sequencing and transformed into M. tuberculosis H37Ra as described 32 . Actively growing M. tuberculosis H37Ra/pUV15tet-mIHF-RFP was exposed with different concentration CFZ at 37°C for 72 hours and then ATc was added to induce the fusion protein expression. The M. tuberculosis cells expressing the pUV15tet-mIHF-RFP constructs were visualized by using a Nikon Eclipse E800 fluorescence microscope with a SPOT slider color camera at different time points.
Acknowledgements
The work was supported in part by NIH grants AI099512 and AI108535. Figure 1 Potential target proteins binding to CFZ analyzed by SDS-PAGE. M. tuberculosis whole-cell lysates were loaded onto the CFZ-linked and blank control columns, and the proteins that bound to the control agarose bead column (Lane 1) and CFZ-linked column (Lane 2) were analyzed by SDS-PAGE with Lane M as the protein molecular weight marker. The protein bands were excised and subjected to mass spectrometry analysis, which identified these proteins as RplD, RplQ, RpsQ, RplT and mIHF, respectively.
Complex formation between CFZ and mIHF as shown by acidic native PAGE gel. a, Concentration-dependent complex formation of CFZ and mIHF. mIHF (180 ng) was incubated with CFZ at different concentrations at 0, 2, 4, 8, 16, 32, 64, 128 and 256 μg/ml (from left to right side, repectively) in 15 μl reaction. b, Rifampin (RIF) as a control drug did not interact with mIHF. mIHF (180 ng) was incubated with RIF at different concentrations at 0, 4, 8, 16, 32, 64, 128, 256 and 512 μg/ml (from left to right side, repectively) in 15 μl reaction. c, The control group oil red O did not interact with mIHF. mIHF (180 ng) was incubated with oil red O at different concentrations at 0, 3.9, 7.8, 15.6, 31.3, 62.5,125, 250 and 500 μg/ml (from left to right side, repectively) in 15 μl reaction. was used as the control without mIHF and CFZ (Lane 1). The mIHF (50 ng) was incubated with different concentrations of CFZ from 0 to 800 μg/ml on ice for 15 min, and the mIHF DNA mixture was run on 0.5% agarose gel to visualize the CFZ inhibition of mIHF interaction with DNA stained by EtBr (Lanes 2 to 13). b, No inhibition of mIHF binding to linear plasmid DNA by RIF. DNA was used as the control without mIHF and RIF (Lane 1). The mIHF was incubated with different concentrations of RIF from 0 to 800 μg/ml on ice for 15 min and analyzed as above (Lanes 2 to 13). c, No inhibition of mIHF binding to linear plasmid DNA by oil red O. DNA was used as the control without mIHF and oil red O (Lane 1). The mIHF was incubated with different concentrations of oil red O from 0 to 800 μg/ml on ice for 15 min and the mixture was analyzed as above (Lanes 2 to 13).
Figure 4 CFZ alters the localization of mIHF in M. tuberculosis. a, mIHF-RFP fusion protein was induced by ATc (5 ng/ml) for 6 days in M. tuberculosis H37Ra/pUV15tet-mIHF-RFP strain. b, mIHF-RFP fusion protein was induced by ATc for 3 days and then followed by 5 µg/ml CFZ exposure for 3 days in M. tuberculosis H37Ra/pUV15tet-mIHF-RFP strain. M. tuberculosis H37Ra/pUV15tet-mIHF-RFP strain was exposed to 0 µg/ml (c), 1 µg/ml (d), 5 µg/ml (e), and 25 µg/ml (f) of CFZ for 3 days followed by induction by 5 ng/ml ATc for 3 days. Differential interference contrast (DIC), red fluorescent protein (RFP) and merged images are presented. The scale bar represents 10 μ m.
